- Home
- / SwanBio Therapeutics
SwanBio Therapeutics
Total Funding
$52 M
SwanBio Therapeutics Summary
Company Summary
- Overview
- SwanBio Therapeutics is a gene therapy company developing medicines for the treatment of neurological diseases. It uses adeno-associated virus (AAV) to deliver therapeutic genes to the central nervous system to achieve therapeutic effects.
- Type
- Private
- Status
- Active
- Founded
- 2018
- HQ
- Philadelphia, PA, US | view all locations
- Website
- https://www.swanbiotx.com/
- Cybersecurity rating
Table of Contents
Key People
Karen Kozarsky, Chief Scientific Officer
Carolyn Carroll, Chief People Officer
Michael Alexander, General Counsel, Head of IP
LocationsView all
2 locations detected
Philadelphia, PA HQ
United States
150 Monument Rd
Cambridge, MA
United States
1 Broadway